• unexplained syncope;
  • arrhythmia;
  • risk factor;
  • scoring system


  1. Top of page
  2. Abstract
  3. References

Objectives: To develop and validate a risk score predicting arrhythmias for patients with syncope remaining unexplained after emergency department (ED) noninvasive evaluation. Methods: One cohort of 175 patients with unexplained syncope (Geneva, Switzerland) was used to develop and cross-validate the risk score; a second cohort of 269 similar patients (Pittsburgh, PA) was used to validate the system. Arrhythmias as a cause of syncope were diagnosed by cardiac monitoring or electrophysiologic testing. Data from the patient's history and 12-lead emergency electrocardiography (ECG) were used to identify predictors of arrhythmias. Logistic regression was used to identify predictors for the risk-score system. Risk-score performance was measured by comparing the proportions of patients with arrhythmias at various levels of the score and receiver operating characteristic (ROC) curves. Results: The prevalence of arrhythmic syncope was 17% in the derivation cohort and 18% in the validation cohort. Predictors of arrhythmias were abnormal ECG (odds ratio [OR]: 8.1, 95% confidence interval [CI] = 3.0 to 22.7), a history of congestive heart failure (OR: 5.3, 95% CI = 1.9 to 15.0), and age older than 65 (OR: 5.4, 95% CI = 1.1 to 26.0). In the derivation cohort, the risk of arrhythmias ranged from 0% (95% CI = 0 to 6) in patients with no risk factors to 6% (95% CI = 1 to 15) for patients with one risk factor, 41% (95% CI = 26 to 57) for patients with two risk factors, and 60% (95% CI = 32 to 84) for those with three risk factors. In the validation cohort, these proportions varied from 2% (95% CI = 0 to 7) with no risk factors to 17% (95% CI = 10 to 27) with one risk factor, 35% (95% CI = 24 to 46) with two risk factors, and 27% (95% CI = 6 to 61) with three risk factors. Areas under the ROC curves ranged from 0.88 (95% CI = 0.84 to 0.91) for the derivation cohort to 0.84 (95% CI = 0.77 to 0.91) after cross-validation within the same cohort and 0.75 (95% CI = 0.68 to 0.81) for the external validation cohort. Conclusions: In patients with unexplained syncope, a risk score based on clinical and ECG factors available in the ED identifies patients at risk for arrhythmias.


  1. Top of page
  2. Abstract
  3. References
  • 1
    Kapoor WN. Syncope. N Engl J Med. 2000; 343:185662.
  • 2
    Linzer M., Yang EH, Estes NA 3rd, Wang P., Vorperian VR, Kapoor WN, For the Clinical Efficacy Assessment Project of the American College of Physicians. Diagnosing syncope. Part 1: value of history, physical examination, and electrocardiography. Ann Intern Med. 1997; 126:98996.
  • 3
    Kapoor WN. Evaluation and outcome of patients with syncope. Medicine. 1990; 69:16075.
  • 4
    Day SC, Cook EF, Funkenstein H., Goldman L.. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med. 1982; 73:1523.
  • 5
    Martin GJ, Adams SL, Martin HG, Mathews J., Zull D., Scanlon PJ. Prospective evaluation of syncope. Ann Emerg Med. 1984; 13:499504.
  • 6
    Linzer M., Yang EH, Estes NA 3rd, Wang P., Vorperian VR, Kapoor WN, For the Clinical Efficacy Assessment Project of the American College of Physicians. Diagnosing syncope, Part 2: unexplained syncope. Ann Intern Med. 1997; 127:7686.
  • 7
    Brignole M., Alboni P., Benditt D., et al. For the Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J. 2001; 22:1256305.
  • 8
    Kapoor WN, Karpf M., Maher Y., Miller RA, Levey GS. Syncope of unknown origin: the need for a more cost-effective approach to its diagnostic evaluation. JAMA. 1982; 247:268791.
  • 9
    Nyman J., Krahn A., Pland P., Criffiths S., Manda V.. The costs of recurrent syncope of unknown origin in elderly patients. PACE. 1999; 22:138694.
  • 10
    American College of Emergency Physicians. Clinical Policy: critical issues in the evaluation and management of patients presenting with syncope. Ann Emerg Med. 2001; 37:7716.
  • 11
    Sarasin FP, Louis-Simonet M., Carballo D., et al. Prospective evaluation of patients with syncope: a population-based study. Am J Med. 2001; 111:17784.
  • 12
    Guidelines for Clinical Electrophysiological and Catheter Ablation Procedures. A report of the American College of Cardiology/American heart Association Task Force on practice guidelines. Developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation. 1995; 92:67391.
  • 13
    Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y., Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001; 54:77481.
  • 14
    Krol RB, Moraby F., Flaker GC, et al. Electrophysiologic testing in patients with unexplained syncope: clinial and non invasive predictors of outcome. J Am Coll Cardiol. 1987; 10:35863.
  • 15
    Denes P., Uretz E., Ezri MD, Borbola J.. Clinical predictors of electrophysiologic findings in patients with syncope of unknown origin. Arch Intern Med. 1988; 148:19228.
  • 16
    Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 1993; 21:1106.
  • 17
    Ho KK, Anderson KM, Kannel WB, Grossman W., Levy D.. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993; 88:10715.
  • 18
    Martin TP, Hanusa BH, Kapoor WN. Risk stratification of patients with syncope. Ann Emerg Med. 1997; 29:45966.
  • 19
    McGinn TG, Guyatt GH, Wyer PC, Naylor DC, Stiell IG, Richardson WS, For the Evidence-based Medicine Working Group. Users' guides to the litterature. XXII; how to use articles about clinical decision rules. JAMA. 2000; 284:7984.
  • 20
    Oh JH, Hanusa BH, Kapoor WN. Do symptoms predict cardiac arrhythmias in patients with syncope Arch Intern Med. 1999; 159:37580.
  • 21
    Alboni P., Brignole M., Menozzi C., et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001; 37:19218.